It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
Categories
Health Care
IPO News: Here are a few things to note when Dice Therapeutics goes public
Many pharma companies are lining up to go public and this week will see Dice Therapeutics join the group. The California-based firm,
Avalo Therapeutics CEO Mike Cola on product pipeline and market potential
Credit:DavidBGray on iStock What’s the significance of the name change and why now? Mike: The why now is because we have really
BeyondSpring Inc (BYSI) Q2 2021 Earnings Call Transcript
BeyondSpring Inc (NASDAQ:BYSI) Q2 2021 earnings call dated Sep. 10, 2021. Corporate Participants: Monique Kosse -- Investor Relations Lan Huang -- Co-founder, Chairman & Chief Executive
Avid Bioservices Inc (CDMO) Q1 2021 Earnings Call Transcript
Avid Bioservices Inc (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 08, 2021. Corporate Participants: Tim Brons -- Avid's Investor Relations Group Nicholas
HealthEquity Inc (HQY) Q2 2022 Earnings Call Transcript
HealthEquity Inc (NASDAQ: HQY) Q2 2022 earnings call dated Sep. 08, 2021. Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President
Affimed NV (AFMD) Q2 2021 Earnings Call Transcript
Affimed NV (NASDAQ: AFMD) Q2 2021 earnings call dated Sep. 08, 2021 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi
IPO Alert: COVID-19 test maker Cue Health is all set to go public
Just eight months into the year, IPO activity has already reached all-time highs, with tech firms and biotechnology startups leading the rally.
Veeva Systems inc (VEEV) Q2 2022 Earnings Call Transcript
Veeva Systems Inc. (NYSE: VEEV) Q2 2022 earnings call dated Sep. 01, 2021 Corporate Participants: Ato Garrett -- Investor Relations Peter Gassner -- Founder and Chief
111 Inc (YI) Q2 2021 Earnings Call Transcript
111 Inc (NASDAQ: YI) Q2 2021 earnings call dated Aug. 27, 2021. Corporate Participants: Monica Mu -- Investor Relations Director Liu Junling
Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript
Catalent, inc (NYSE: CTLT) Q4 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Paul Surdez -- Vice President of Investor Relations John Chiminski -- Chair
Medicure Inc (MPH) Q2 2021 Earnings Call Transcript
Medicure Inc (CVE:MPH) Q2 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Albert D. Friesen -- Chief Executive Officer and Chairman
Predictmedix COO Rahul Kushwah: We aim to be a major player in workplace safety
Courtesy: Predictmedix What’s so special about your safe entry station and what’s the market potential? Rahul: At Predictmedix, our focus is all
Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript
Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive Officer and
Ramsay Health Care Ltd (RHC) Q4 2021 Earnings Call Transcript
Ramsay Health Care Ltd (ASX:RHC) Q4 2021 earnings call dated Aug. 25, 2021. Corporate Participants: Craig McNally -- Managing Director and Chief
Lannett Company Inc (LCI) Q4 2021 Earnings Call Transcript
Lannett Company Inc (NYSE: LCI) Q4 2021 earnings call dated Aug. 25, 2021. Corporate Participants: Robert Jaffe -- Owner Timothy C. Crew --
Medtronic PLC (MDT) Q1 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2022 earnings call dated Aug. 24, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
Moderna (MRNA): Here are a few points to note while considering this stock
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of the year
IPO Alert: What investors need to know about Procept BioRobotics’ upcoming market debut
The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year as the
IPO News: Should you invest in RenovoRx’s upcoming IPO?
As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the IPO market
Agilent Technologies, Inc. (A) Q3 2021 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE: A) Q3 2021 earnings call dated Aug. 17, 2021 Corporate Participants: Parmeet Ahuja -- Vice President, Investor Relations Mike McMullen -- President